Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tetricus is a precision psychiatry company dedicated to transforming mental health care through advanced machine learning and data analytics. The company's platform integrates clinical, behavioral, and biological data to provide objective diagnostic support and treatment response predictions for complex psychiatric conditions. By identifying unique patient phenotypes, Tetricus enables clinicians to move beyond subjective assessments toward personalized, evidence-based treatment plans. Their primary focus includes major depressive disorder, schizophrenia, and other high-burden mental health conditions. Ultimately, Tetricus aims to improve patient outcomes and reduce the healthcare costs associated with ineffective psychiatric treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tetricus.